CSIMarket
 


Renovorx Inc   (RNXT)
Other Ticker:  
 
 

RNXT's Operating Income Growth by Quarter and Year

Renovorx Inc 's Operating Income results by quarter and year




RNXT Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 1.40 0.00 0.00
III Quarter September -2.16 -1.40 0.00 0.00
II Quarter June -2.61 0.00 0.00 0.00
I Quarter March -3.01 0.00 0.00 0.00
FY   -7.78 0.00 0.00 0.00



RNXT Operating Income third quarter 2022 Y/Y Growth Comment
Renovorx Inc in the third quarter 2022 recorded Operating Loss of $ -2.16 millions.

According to the results reported in the third quarter 2022, Renovorx Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Renovorx Inc ' s Operating Income no change of % ranks overall at the positon no. in the third quarter 2022.

Explain Operating Income growth


RNXT Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Renovorx Inc 's third quarter 2022 Operating Income $ -2.16 millions RNXT's Income Statement
Renovorx Inc 's third quarter 2021 Operating Income $ -1.40 millions Quarterly RNXT's Income Statement
New: More RNXT's historic Operating Income Growth >>


RNXT Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Renovorx Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RNXT's III. Quarter Q/Q Operating Income Comment
Despite the fact, that Renovorx Inc in the III. Quarter 2022 revealed Operating Loss of $ -2.16 millions, some analyst mentioned, that current results point to improvement in contrast to the -2.61 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Renovorx Inc achieved highest sequential Operating Income growth. While Renovorx Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RNXT's III. Quarter Q/Q Operating Income Comment
Despite the fact, that Renovorx Inc in the III. Quarter 2022 revealed Operating Loss of $ -2.16 millions, some analyst point out, that those numbers show slight up side in contrast to the -2.61 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Renovorx Inc achieved highest sequential Operating Income growth. While Renovorx Inc 's Operating Income growth quarter on quarter, overall rank is .


Renovorx Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Operating Income 12 Months Ending $ -6.39 $ -5.62 $ 0.00 $ 0.00 $ 0.00
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Renovorx Inc ' has realized cumulative trailing twelve months Operating Loss of $ -6 millions in the Sep 30 2022 period.
The results are getting worse as the cumulative Operating Loss is becoming larger from $ -5.62 millions for the period from Jun 30 2022 to Sep 30 2021 and $ -2.61 millions for the twelve months ending in the quarter a year ago Esme  Wilson told.

Renovorx Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Renovorx Inc ' has realized cumulative trailing twelve months Operating Loss of $ -6 millions in the Sep 30 2022 period.
The results are detiriorating as the cumulative Operating Loss is inflating from $ -5.62 millions in TTM ending quarter Jun 30 2022 and $ -2.61 millions for the twelve months ending in the quarter a year ago.

Renovorx Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
RNXT's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for RNXT's Competitors
Operating Income Growth for Renovorx Inc 's Suppliers
Operating Income Growth for RNXT's Customers

You may also want to know
RNXT's Annual Growth Rates RNXT's Profitability Ratios RNXT's Asset Turnover Ratio RNXT's Dividend Growth
RNXT's Roe RNXT's Valuation Ratios RNXT's Financial Strength Ratios RNXT's Dividend Payout Ratio
RNXT's Roa RNXT's Inventory Turnover Ratio RNXT's Growth Rates RNXT's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2022
Catalyst Pharmaceuticals Inc 79.25%$ 79.249 millions
Biogen Inc 65.63%$ 65.630 millions
Viatris Inc 56.63%$ 56.628 millions
Iqvia Holdings Inc 56.29%$ 56.291 millions
Amneal Pharmaceuticals Inc 55.54%$ 55.543 millions
Medpace Holdings Inc 44.89%$ 44.894 millions
Collegium Pharmaceutical inc 44.65%$ 44.653 millions
Stryker Corp40.77%$ 40.767 millions
United Therapeutics Corporation37.43%$ 37.429 millions
Central Garden and Pet Co34.28%$ 34.284 millions
Iradimed Corporation33.87%$ 33.866 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

JXN's Profile

Stock Price

JXN's Financials

Business Description

Fundamentals

Charts & Quotes

JXN's News

Suppliers

JXN's Competitors

Customers & Markets

Economic Indicators

JXN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071